down arrow

ResMed, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US7611521078
USD
251.51
0.07 (0.03%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
DexCom, Inc.
ResMed, Inc.
Edwards Lifesciences Corp.
Agilent Technologies, Inc.
West Pharmaceutical Services, Inc.
IDEXX Laboratories, Inc.
Align Technology, Inc.
GE Healthcare Technologies, Inc.
Zimmer Biomet Holdings, Inc.
Becton, Dickinson & Co.
Mettler-Toledo International, Inc.
Why is ResMed, Inc. ?
1
High Management Efficiency with a high ROCE of 25.79%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.50 times
3
Healthy long term growth as Operating profit has grown by an annual rate 15.84%
4
The company has declared Positive results for the last 5 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at USD 1,751.59 MM
  • ROCE(HY) Highest at 25.86%
  • DEBT-EQUITY RATIO (HY) Lowest at -6.21 %
5
With ROCE of 30.33%, it has a attractive valuation with a 8.90 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 1.83%, its profits have risen by 31.5% ; the PEG ratio of the company is 1.2
6
Company is among the highest 1% of companies rated by MarketsMojo across all 4,000 stocks
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to ResMed, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is ResMed, Inc. for you?

Low Risk, Medium Return

Absolute
Risk Adjusted
Volatility
ResMed, Inc.
2.31%
0.70
26.77%
S&P 500
13.22%
0.64
20.20%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
11.72%
EBIT Growth (5y)
15.84%
EBIT to Interest (avg)
41.25
Debt to EBITDA (avg)
0.50
Net Debt to Equity (avg)
-0.04
Sales to Capital Employed (avg)
0.79
Tax Ratio
16.74%
Dividend Payout Ratio
22.30%
Pledged Shares
0
Institutional Holding
71.73%
ROCE (avg)
25.79%
ROE (avg)
21.53%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
36
Industry P/E
Price to Book Value
8.57
EV to EBIT
29.34
EV to EBITDA
25.87
EV to Capital Employed
8.90
EV to Sales
9.42
PEG Ratio
1.15
Dividend Yield
2.62%
ROCE (Latest)
30.33%
ROE (Latest)
23.58%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

23What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 1,751.59 MM

ROCE(HY)

Highest at 25.86%

DEBT-EQUITY RATIO (HY)

Lowest at -6.21 %

DIVIDEND PER SHARE(HY)

Highest at USD 5.52

NET SALES(Q)

Highest at USD 1,347.99 MM

OPERATING PROFIT(Q)

Highest at USD 530.86 MM

OPERATING PROFIT MARGIN(Q)

Highest at 39.38 %

PRE-TAX PROFIT(Q)

Highest at USD 456.13 MM

NET PROFIT(Q)

Highest at USD 378.11 MM

RAW MATERIAL COST(Y)

Fallen by -4.19% (YoY

CASH AND EQV(HY)

Highest at USD 2,155.24 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 2.44 times

EPS(Q)

Highest at USD 2.58

-3What is not working for the Company
DEBTORS TURNOVER RATIO(HY)

Lowest at 5.52 times

DIVIDEND PAYOUT RATIO(Y)

Lowest at 20.52%

Here's what is working for ResMed, Inc.
Operating Cash Flow
Highest at USD 1,751.59 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Sales
Highest at USD 1,347.99 MM and Grown
In each period in the last five periods
MOJO Watch
Near term sales trend is very positive

Net Sales (USD MM)

Operating Profit
Highest at USD 530.86 MM and Grown
In each period in the last five periods
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (USD MM)

Operating Profit Margin
Highest at 39.38 % and Grown
In each period in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at USD 456.13 MM and Grown
In each period in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD 378.11 MM and Grown
In each period in the last five periods
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Debt-Equity Ratio
Lowest at -6.21 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Dividend per share
Highest at USD 5.52 and Grown
In each year in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (USD)

EPS
Highest at USD 2.58
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Cash and Eqv
Highest at USD 2,155.24 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Inventory Turnover Ratio
Highest at 2.44 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost
Fallen by -4.19% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at USD 74.29 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Depreciation
At USD 74.29 MM has Grown at 43.11%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (USD MM)

Here's what is not working for ResMed, Inc.
Debtors Turnover Ratio
Lowest at 5.52 times and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Dividend Payout Ratio
Lowest at 20.52%
in the last five years
MOJO Watch
Company is distributing lower proportion of profits generated as dividend

DPR (%)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."